Clinical Trials Logo

Filter by:
NCT ID: NCT01913392 Completed - Obesity, Morbid Clinical Trials

Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate

Start date: July 18, 2013
Phase:
Study type: Observational

A prospective clinical trial will study the effects of laparoscopic sleeve gastrectomy in the potential renal transplant candidate who is denied acceptance due mainly to the morbid obesity.

NCT ID: NCT01913210 Completed - Blood Pressure Clinical Trials

Effect of Ginseng on Blood Pressure

Start date: April 2013
Phase: N/A
Study type: Observational

To determine the effect of ginseng on blood pressure control.

NCT ID: NCT01913093 Completed - Clinical trials for Childhood Leukemia Survivors

N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors

NPG
Start date: July 2013
Phase:
Study type: Observational

To find possible therapeutic targets to help prevent long-term brain and behavioural side effects in survivors of childhood leukemia that may have been caused by chemotherapy (Treatment-Related late Adverse Neuro-Cognitive Effects: TRANCE). The study hypothesis is that genetic variations of the elements in the folate-related cycles and methotrexate disposition networks are associated with the deficit phenotype (TRANCE) of childhood leukemia survivors.

NCT ID: NCT01912807 Completed - Clinical trials for Postoperative Vomiting

Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic?

DEXPO
Start date: December 2013
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the efficacy of intraoperative intravenous dextrose in preventing POV in pediatric population undergoing dental day surgery. Post-operative vomiting (POV) in children is a frequent complication. Studies using intravenous (IV) fluids containing dextrose in the perioperative period have shown improvement of POV in adults. Similar studies have not been done in children. Knowing that Intravenous (IV) fluids containing dextrose are safe and commonly used in the paediatric population, this intervention could potentially reduce the amount of rescue antiemetic medications and improve recovery in same-day surgery paediatric patients.

NCT ID: NCT01912560 Completed - Clinical trials for Hypercholesterolemia

Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia

PATHWAYS I
Start date: July 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of different doses of CAT-2003 in patients with hyperlipidemia when CAT-2003 is taken for 4 weeks. The study will evaluate effects of CAT-2003 on (1) fasting triglycerides and non-HDL-C in patients with moderate hypertriglyceridemia and (2) fasting LDL-C levels in combination with a statin in patients with hypercholesterolemia who are on a statin.

NCT ID: NCT01912534 Completed - Clinical trials for Hypertrophic Cardiomyopathy

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

VANISH
Start date: March 2014
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to determine whether treatment with valsartan will have beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that reflect myocardial structure, function and biochemistry.

NCT ID: NCT01912456 Completed - Clinical trials for Hereditary Angioedema Types I and II

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Start date: January 2014
Phase: Phase 3
Study type: Interventional

The aim of this study is to assess the efficacy of C1-esterase inhibitor in preventing hereditary angioedema attacks when it is administered under the skin of subjects with hereditary angioedema. The safety of C1-esterase inhibitor will also be assessed. Each subject will enter a run-in period of up to 8-weeks. Subjects who complete the run-in period and who are eligible will then enter the treatment phase which comprises two sequential treatment periods. In the treatment phase, subjects will be randomized to one of four arms consisting of treatment with low- or higher-volume C1-esterase inhibitor in one treatment period and treatment with low- or higher-volume placebo in the other treatment period. The study will measure the number of hereditary angioedema attacks that subjects experience while receiving each treatment.

NCT ID: NCT01912365 Completed - Bone Fractures Clinical Trials

Splinting Versus Casting for Type I Supracondylar Fractures

Start date: August 2013
Phase: N/A
Study type: Observational

Elbow fractures are very common in young children. Type I supracondylar fractures are stable fractures to the elbow that are treated conservatively across the world and typically heal very well without complications. There are several treatment options, including an above elbow cast or long arm splint. This study aims to determine if one treatment is no worse than the other in order to standardize the treatment of these fractures at our institution. The investigators hope to save families from extra hospital visits and reduce the amount of x-rays required for treatment of these fractures.

NCT ID: NCT01912235 Completed - Healthy Clinical Trials

Arginine Synthesis in Healthy Adult Humans

Start date: September 2007
Phase: N/A
Study type: Interventional

Arginine synthesis in mammals is a complex process involving at least 8 enzymes and intracellular and interorgan transfer of substrates. The investigators have shown in our neonatal studies that there is no conversion of glutamate to arginine but proline label appears in ornithine, citrulline and arginine. It is clear therefore that arginine is synthesized in human neonates from proline. In adults the source of the carbon backbone is less clear.

NCT ID: NCT01912183 Completed - Pediatric Obesity Clinical Trials

Family-centred E-health in Pediatric Weight Management: A Pilot Study

Start date: July 2014
Phase: N/A
Study type: Interventional

This is a pilot study to examine the feasibility of implementing an objective physical activity and sleep monitoring tool into a pediatric weight management program in conjunction with a personal health record (PHR) for children and their families. This feasibility study is intended to provide proof of concept in the incorporation of monitoring devices within the PHR for pediatric patients and their families. Additionally, the investigators will examine whether the PHR helps to empower pediatric patients, their families and the health care team to more effectively monitor the patient's behavior change. Participants will be randomized to receive, or not receive, augmented communication with the health care team between clinical in person visits.